Lisa G. Rider, MD
Deputy Chief of the Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, National Institutes of Health, and Chairman, Cure JM Medical Advisory Board, National Institute of Environmental Health Sciences, National Institutes of Health
Lisa Rider, MD, a pediatric rheumatologist, is Deputy Chief of the Environmental Autoimmunity Group, National Institute of Environmental Health Science, National Institutes of Health, in Bethesda, Maryland, USA. She received her BA and MD degrees from Duke University. After completing her pediatrics residency and a clinical fellowship in pediatric rheumatology at the University of Washington/Seattle Children’s Hospital, she became a Research Associate in NIAMS, National Institutes of Health. She then joined Dr. Frederick Miller’s laboratory at the Center for Biologics, Food and Drug Administration, and later became Deputy Chief of the group, which moved to NIEHS in 2002. For the past 11 years, Dr. Rider has also been Clinical Professor of Medicine at George Washington University, where she sees patients and leads research on juvenile myositis in the Cure JM Center for Excellence. Dr. Rider’s research has focused on juvenile myositis, in which she has led the international development of validated outcome measures and trial response criteria, defined the major autoantibody phenotypes and associated outcomes, studied genetic and environmental disease risk factors, and led clinical trials of new therapies. She has co-authored more than 145 peer-reviewed publications, 45 book chapters and review articles, and was the lead editor of a book published by Cure JM, Myositis and You. She has received several awards in recognition of her contributions, including Physician Researcher of the Year by the US Public Health Service (2011), the 2017 Cure JM Lifetime Achievement in Research award, and The Myositis Association’s 25th Anniversary Research Award: For Outstanding Contributions to Myositis Research over the past 15 years.
Lisa is speaking at
Authors: Everyone except Children 13 and youngerThis general session will review what Cure JM Foundation is doing to improve the lives of families battling JM; from the latest research being funded to advancing new Centers of Excellence in JM Research to build awareness of JM. This session will also include insights from the top JM researchers.
Authors: Everyone except Children 13 and youngerLabs results are an essential tool in managing a patient's treatment for JM. To the non-medically trained, labs can also be a great source of confusion. In this sessions the doctors will help you better understand lab results and what they may indicate.
Authors: Everyone except Children 13 and youngerYou've heard about the four Cure JM Centers of Excellence in Seattle, Chicago, Washington D.C. and Raleigh-Durham North Carolina. Join us to learn more about adding a Cure JM Center of Excellence to you family's care team. This session features a presentation and Q&A session.